|
HAUS6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.392500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.062700E-03 |
| Normal-vs-Stage2 |
9.66040000000001E-05 |
| Normal-vs-Stage3 |
5.520600E-03 |
| Normal-vs-Stage4 |
7.59610000000688E-05 |
| Stage1-vs-Stage2 |
3.220500E-02 |
| Stage1-vs-Stage3 |
6.877000E-01 |
| Stage1-vs-Stage4 |
3.906200E-02 |
| Stage2-vs-Stage3 |
1.165430E-01 |
| Stage2-vs-Stage4 |
6.685000E-01 |
| Stage3-vs-Stage4 |
1.620620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.779100E-03 |
| Normal-vs-AfricanAmerican |
5.502600E-03 |
| Normal-vs-Asian |
1.698360E-02 |
| Caucasian-vs-AfricanAmerican |
3.793600E-01 |
| Caucasian-vs-Asian |
9.197200E-01 |
| AfricanAmerican-vs-Asian |
4.629200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.443200E-04 |
| Normal-vs-Female |
7.570600E-04 |
| Male-vs-Female |
5.975400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.857700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.400000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.952700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.633600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.878020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.618300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.357200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.383400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.992600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.692200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.595400E-01 |
| Classical-VS-Follicular |
1.64047999999806E-05 |
| Classical-VS-Other |
7.722000E-01 |
| Classical-VS-Normal |
6.718600E-03 |
| Tall-VS-Follicular |
2.901100E-03 |
| Tall-VS-Other |
9.368000E-01 |
| Tall-VS-Normal |
2.492600E-01 |
| Follicular-VS-Other |
2.915000E-01 |
| Follicular-VS-Normal |
8.51789999978259E-07 |
| Other-VS-Normal |
7.451200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.88690000000924E-05 |
| Normal-vs-N1 |
1.484690E-03 |
| N0-vs-N1 |
8.190600E-01 |
|
|
